Xenetic Biosciences, Inc.

XBIO · Nasdaq · SIC 2834: Pharmaceutical Preparations
250
SEC Filings

Business Summary

PART I Overview We are a biopharmaceutical company focused on advancing innovative immuno-oncology technologies addressing difficult to treat cancers. Our proprietary DNase technology is designed to improve outcomes of existing treatments, including immunotherapies, by targeting neutrophil extracellular traps (NETs), which are involved in cancer growth, metastasis and progression, and contribute to immunotherapy, chemotherapy and radiotherapy resistance. The DNase technology is designed to targe...

Next Earnings

Q2 FY2026 — expected 2026-08-13

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionXBIOdiscussed_in_filing Cybersecurity
topic_mentionXBIOdiscussed_in_filing Trusted Computing
topic_mentionXBIOdiscussed_in_filing Blockchain & Crypto
topic_mentionXBIOdiscussed_in_filing Regulation
topic_mentionXBIOdiscussed_in_filing Healthcare & Bio
topic_mentionXBIOdiscussed_in_filing Platform & Ecosystem
topic_mentionXBIOdiscussed_in_filing Sovereign & Government
topic_mentionXBIOdiscussed_in_filing Cybersecurity
topic_mentionXBIOdiscussed_in_filing Trusted Computing
topic_mentionXBIOdiscussed_in_filing Blockchain & Crypto
topic_mentionXBIOdiscussed_in_filing Regulation
topic_mentionXBIOdiscussed_in_filing Healthcare & Bio
topic_mentionXBIOdiscussed_in_filing Platform & Ecosystem
topic_mentionXBIOdiscussed_in_filing Sovereign & Government
topic_mentionXBIOdiscussed_in_filing Cybersecurity
topic_mentionXBIOdiscussed_in_filing Trusted Computing
topic_mentionXBIOdiscussed_in_filing Blockchain & Crypto
topic_mentionXBIOdiscussed_in_filing Regulation
topic_mentionXBIOdiscussed_in_filing Healthcare & Bio
topic_mentionXBIOdiscussed_in_filing Platform & Ecosystem

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-122025-12-310001683168-26-001737EDGAR67K words
2025-03-182024-12-310001683168-25-001686EDGAR—
2024-03-212023-12-310001683168-24-001594EDGAR—
2023-03-222022-12-310001683168-23-001674EDGAR—
2022-03-222021-12-310001683168-22-001839EDGAR—
2021-03-162020-12-310001683168-21-000969EDGAR—
2020-03-262019-12-310001683168-20-000967EDGAR—
2019-03-292018-12-310001683168-19-000840EDGAR—
2018-03-302017-12-310001683168-18-000831EDGAR—
2017-03-312016-12-310001683168-17-000749EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001683168-25-008259EDGAR14K words
2025-08-122025-06-300001683168-25-005983EDGAR—
2025-05-132025-03-310001683168-25-003496EDGAR—
2024-11-122024-09-300001683168-24-007903EDGAR—
2024-08-132024-06-300001683168-24-005572EDGAR—
2024-05-092024-03-310001683168-24-003172EDGAR—
2023-11-092023-09-300001683168-23-007820EDGAR—
2023-08-102023-06-300001683168-23-005513EDGAR—
2023-05-112023-03-310001683168-23-003201EDGAR—
2022-11-092022-09-300001683168-22-007447EDGAR—
2022-08-112022-06-300001683168-22-005567EDGAR—
2022-05-122022-03-310001683168-22-003503EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-130001683168-26-001744EDGAR1K words
2026-01-090001683168-26-000196EDGAR—
2025-12-110001683168-25-009076EDGAR—
2025-11-130001683168-25-008288EDGAR—
2025-10-140001683168-25-007528EDGAR—
2025-08-130001683168-25-006001EDGAR—
2025-05-140001683168-25-003513EDGAR—
2025-04-100001683168-25-002396EDGAR—
2025-03-190001683168-25-001693EDGAR—
2024-12-130001683168-24-008712EDGAR—

250 total filings indexed. 218 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Company Identity

CIK0001534525
TickerXBIO
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedNV

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: f861818beac86ef75c2ffb3f1eaa24dd0764a20458524520f4450cb61c5b2760
parent: fdc57f444b7ab8ae5e51ac057e82bf3db5621899a10fa40d42ba94b5e22dd8bd
content hash: 1ef775e6acd427e7198bd5710c7b76bc5e1b6b965b7c4537fb05d804b449f6b9
signed: 2026-04-13T04:48:17.388Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf